MIRA Pharmaceuticals, Inc. Travel and Entertainment Expense
MIRA Pharmaceuticals, Inc. (MIRA) reported Travel and Entertainment Expense of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:TravelAndEntertainmentExpense · last filed 2025-03-28
- MIRA Pharmaceuticals, Inc. travel and entertainment expense for the quarter ending 2024-12-31 was -$40.00K.
- MIRA Pharmaceuticals, Inc. travel and entertainment expense for the quarter ending 2024-09-30 was $30.00K.
- MIRA Pharmaceuticals, Inc. travel and entertainment expense for the quarter ending 2023-03-31 was $50.00K.
- MIRA Pharmaceuticals, Inc. travel and entertainment expense for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- MIRA Pharmaceuticals, Inc. travel and entertainment expense for fiscal 2023 was $500.00K, a 70.59% decline from fiscal 2022.
- MIRA Pharmaceuticals, Inc. travel and entertainment expense for fiscal 2022 was $1.70M.
| Period end | Travel and Entertainment Expense 3 month | Travel and Entertainment Expense 6 month | Travel and Entertainment Expense 9 month | Travel and Entertainment Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$10.00K derived: sum of 2 quarters · filed 2025-03-28 | $0.00 10-K · filed 2025-03-28 | |
| 2024-09-30 | $30.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-12 | $40.00K 10-Q · filed 2024-11-12 | ||
| 2024-06-30 | $10.00K 10-Q/A · filed 2024-08-16 | |||
| 2023-12-31 | $500.00K 10-K · filed 2025-03-28 | |||
| 2023-03-31 | $50.00K 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | $1.70M 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |